English 日本語

#Zasocitinib

List of IR information related to "Zasocitinib".

1 IR Posts
1 Companies
6 days ago Last Updated

Filters

Reset
Period:
Importance:
1 IR Posts
4502 Takeda Pharmaceutical Company Limited
2026/03/30
Announcement of Clinical Trial Results Suggesting Rapid and Sustained Improvement of Skin Symptoms with Zasocitinib, an Oral Drug with Once-Daily Dosing Convenience, and Its Potential to Transform Psoriasis Treatment

In the Phase 3 clinical trials of Zasocitinib, approximately 70% of patients achieved complete or near-complete clearance of skin symptoms at 16 weeks. Safety was consistent with previous trials with no new safety signals identified. Submission to the FDA in the United States is planned for fiscal 2026.

#TakedaPharmaceuticalCompany #NewDrugAnnouncement #Zasocitinib
Scroll to Top